Welcome to our dedicated page for Ensign Group SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ensign Group, Inc. (Nasdaq: ENSG) files detailed reports with the U.S. Securities and Exchange Commission that describe its post-acute healthcare operations, skilled nursing and senior living services, and healthcare real estate activities. This SEC filings page brings together those documents, along with AI-powered tools that help explain the information they contain.
Ensign’s current reports on Form 8-K discuss topics such as quarterly financial results, the use of non-GAAP financial measures, and changes in board composition and executive roles. In these filings, the company explains how it calculates measures like Adjusted Net Income, Adjusted Earnings per Share, EBITDA, Adjusted EBITDA, Adjusted EBITDAR, Adjusted EBT and Funds from Operations (FFO) for its Standard Bearer real estate segment. These definitions help investors understand how Ensign evaluates performance in its skilled services and real estate businesses.
Through this page, users can access Ensign’s annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K as they are made available on EDGAR. AI-generated summaries highlight key points from lengthy filings, such as segment descriptions, the role of Standard Bearer Healthcare REIT, Inc., and the company’s approach to non-GAAP metrics. The platform also surfaces relevant information from Forms 3, 4 and 5 related to equity ownership and transactions by directors and officers, giving additional context on insider activity.
By combining real-time SEC updates with AI explanations, this ENSG filings page is intended to make Ensign’s regulatory disclosures more accessible to investors who want to understand its skilled nursing, senior living and healthcare real estate operations in greater depth.
Ensign Group director John O. Agwunobi reported an open-market sale of 392 shares of Common Stock at $199.97 per share. After this transaction, he directly holds 9,295.149 shares. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan.
ENSG submitted a Form 144 notice related to proposed sales of Common Stock. The filing lists planned dispositions tied to restricted stock vesting: 246 units on 04/15/2026 and 146 units on 04/17/2026. It also reports past sales of 246 shares on 01/20/2026 and 146 shares on 01/21/2026, with amounts $44,235.72 and $26,033.26 respectively.
Abbott Swati Bargotra reported acquisition or exercise transactions in this Form 4 filing.
ENSIGN GROUP, INC director Swati Bargotra Abbott received an equity grant of 600 shares of Common Stock. The award carried a price of $0.00 per share, reflecting stock-based compensation rather than a market purchase. These shares vest in three equal annual installments beginning on April 15, 2027. After this grant, Abbott directly owns 20,232 shares of Ensign Group common stock.
Agwunobi John O reported acquisition or exercise transactions in this Form 4 filing.
ENSIGN GROUP, INC director John O. Agwunobi received an equity award of 600 shares of Common Stock as compensation. The grant was recorded at a price of $0.00 per share, indicating it was an award rather than a market purchase. Following this grant, he holds 9,687.149 shares directly. According to the footnote, these shares vest in three equal annual installments beginning April 15, 2027, so the full amount becomes available over a multi-year period rather than immediately.
ENSIGN GROUP, INC director Ann Scott Blouin received an equity grant of 600 shares of Common Stock on April 15, 2026 as a compensation-related award, not an open-market purchase. The award carries no cash exercise price.
The filing states these shares vest in three equal annual installments beginning April 15, 2027, indicating a multi‑year retention incentive. After this grant, Blouin directly holds 23,452 shares of Common Stock in total.
Shaw Daren reported acquisition or exercise transactions in this Form 4 filing.
ENSIGN GROUP, INC director Daren Shaw received an award of 600 shares of Common Stock on April 15, 2026. The award was granted at no cash price per share and is structured as equity compensation rather than an open‑market purchase.
These 600 shares vest in three equal annual installments beginning April 15, 2027, meaning the director earns one-third of the grant each year over three years. After this grant, Shaw directly holds a total of 24,326 shares of ENSIGN GROUP, INC Common Stock.
SMITH BARRY M reported acquisition or exercise transactions in this Form 4 filing.
ENSIGN GROUP, INC director Barry M. Smith received an award of 600 shares of common stock at no cost. These shares vest in three equal annual installments beginning April 15, 2027, meaning one-third becomes available each year. Following this grant, Smith directly holds 22,752 common shares.
Ensign Group director Mark Vincent Parkinson reported both a stock award and a small sale of common shares. On April 15, 2026, he received 600 shares as a grant at $0.00 per share, which vest in three equal annual installments beginning April 15, 2027.
On April 16, 2026, he completed an open-market sale of 100 shares at $196.60 per share pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2025. After these transactions, he directly holds 3,400 shares of Ensign Group common stock.
Mark Parkinson reported a Form 144 notice to sell 100 shares of Common stock of ENSG related to restricted stock vesting dated 04/15/2026. The filing lists a prior sale of 100 shares on 02/09/2026 for $19,800. The broker shown is Fidelity Brokerage Services LLC.
Ensign Group director Barry M. Smith sold 700 shares of Common Stock in an open-market transaction at $196.65 per share. The sale occurred on April 2, 2026 and was made under a pre-arranged Rule 10b5-1 trading plan adopted on July 29, 2025. After this transaction, he directly holds 22,152 shares.